High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
214.49M
+9.5%
0.208
-35.06%
240.33M
+18.28%
0.599
-0.24%
292.87M
+22.17%
1.348
+17.18%
Estimates Revision
The market is revising Upward the revenue expectations for Inspire Medical Systems, Inc. (INSP) for FY2025, with the revenue forecasts being adjusted by 0.01% over the past three months. During the same period, the stock price has changed by -12.35%.
Revenue Estimates for FY2025
Revise Upward
+0.01%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
+4.48%
In Past 3 Month
Stock Price
Go Down
-12.35%
In Past 3 Month
14 Analyst Rating
0Wall Street analysts forecast INSP stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for INSP is 215.83 USD with a low forecast of 174.00 USD and a high forecast of 270.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
11 Buy
3 Hold
0 Sell
Strong Buy
0Current: 126.830
Low
174.00
Averages
215.83
High
270.00
0Current: 126.830
Low
174.00
Averages
215.83
High
270.00
Morgan Stanley
Overweight
downgrade
$200 -> $182
2025-07-15
New
Reason
Morgan Stanley
Price Target
$200 -> $182
2025-07-15
New
downgrade
Overweight
Reason
Morgan Stanley lowered the firm's price target on Inspire Medical to $182 from $200 and keeps an Overweight rating on the shares. The firm continues to like the MedTech industry setup into Q2 on relative stability in procedure volumes and hospital capital expenditures across the space, the analyst tells investors in a research note.
Leerink
Market Perform
downgrade
$176 -> $149
2025-07-14
Reason
Leerink
Price Target
$176 -> $149
2025-07-14
downgrade
Market Perform
Reason
Leerink lowered the firm's price target on Inspire Medical to $149 from $176 and keeps a Market Perform rating on the shares ahead of quarterly results. The firm is updating estimates to reflect financial statement disclosures and its updated views, and price targets of several names in the space to reflect recent changes in valuation premiums.
Keybanc
Tim Rezvan
Buy
Maintains
$234 → $216
2025-04-21
Reason
Keybanc
Tim Rezvan
Price Target
$234 → $216
2025-04-21
Maintains
Buy
Reason
KeyBanc lowered the firm's price target on Inspire Medical to $216 from $234 and keeps an Overweight rating on the shares. The firm believes underlying MedTech trends remain mostly positive heading into Q1 earnings season, but is lowering several price targets to reflect macro concerns around the potential impact of tariffs as well as an increased risk of recession.
Stifel
Jonathan Block
Hold
Maintains
$190 → $175
2025-04-21
Reason
Stifel
Jonathan Block
Price Target
$190 → $175
2025-04-21
Maintains
Hold
Reason
RBC Capital
Shagun Singh
Buy
Maintains
$260 → $215
2025-04-15
Reason
RBC Capital
Shagun Singh
Price Target
$260 → $215
2025-04-15
Maintains
Buy
Reason
RBC Capital analyst Shagun Singh lowered the firm's price target on Inspire Medical to $215 from $260 and keeps an Outperform rating on the shares as part of a broader research note previewing Q1 results for Medical Devices. Q1 underlying procedure volume and capital placements trends were solid with typical seasonality at play, which should position companies under coverage to beat expectations for the quarter, while FX has moved notably to favor large-cap medical device companies with international exposure, which is not factored into consensus estimates for Q1 or 2025, the analyst tells investors in a research note. Tariff impact is likely to be clarified by several companies, though many companies under coverage have low tariff exposure with a substantial U.S. manufacturing footprint or low relative exposure vs. other large caps, the firm adds.
Morgan Stanley
Kallum Titchmarsh
Buy
Maintains
$230 → $220
2025-02-11
Reason
Morgan Stanley
Kallum Titchmarsh
Price Target
$230 → $220
2025-02-11
Maintains
Buy
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Inspire Medical Systems Inc (INSP.N) is 50.00, compared to its 5-year average forward P/E of -5.81. For a more detailed relative valuation and DCF analysis to assess Inspire Medical Systems Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
-5.81
Current PE
50.00
Overvalued PE
215.58
Undervalued PE
-227.20
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
-37.09
Current EV/EBITDA
16.58
Overvalued EV/EBITDA
134.94
Undervalued EV/EBITDA
-209.13
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Undervalued
5Y Average PS
14.10
Current PS
3.84
Overvalued PS
21.98
Undervalued PS
6.22
Financials
Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
INSP News & Events
Events Timeline
(ET)
2025-05-06
09:48:56
Inspire Medical falls -11.9%
2025-05-05 (ET)
2025-05-05
17:17:05
Inspire Medical raises FY25 EPS view to $2.20-$2.30 from $2.10-$2.20
2025-05-05
17:15:25
Inspire Medical reports Q1 EPS 10c, consensus (23c)
Sign Up For More Events
Sign Up For More Events
News
Preview
6.5
06-05NASDAQ.COMAnalysts Forecast 19% Gains Ahead For The Holdings of RWJ
Preview
1.0
05-30NewsfilterInspire Medical Systems, Inc. to Participate in the Wells Fargo 2025 MedTech Innovation Spotlight
Preview
6.0
05-06BenzingaMorgan Stanley Maintains Overweight on Inspire Medical Systems, Lowers Price Target to $200
Sign Up For More News
People Also Watch
FAQ
What is Inspire Medical Systems Inc (INSP) stock price today?
What is Inspire Medical Systems Inc (INSP)'s business?
What is the price predicton of INSP Stock?
What is Inspire Medical Systems Inc (INSP)'s revenue for the last quarter?
What is Inspire Medical Systems Inc (INSP)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Inspire Medical Systems Inc (INSP)'s fundamentals?
How many employees does Inspire Medical Systems Inc (INSP). have?